Mikami, T <br/><br/>
In vivo effects of recombinant human lymphotoxin on human medulloblastoma xenograft: enhancement of antitumor activity of etoposide.  [electronic resource] 

 -  Biotherapy (Dordrecht, Netherlands)  1994 
 - 7-17 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0921-299X 
<br/><br/><label>Standard No.: </label>10.1007/BF01878116  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Cerebellar Neoplasms--pathology<br/>Child<br/>Drug Synergism<br/>Etoposide--pharmacokinetics<br/>Female<br/>Humans<br/>Indicators and Reagents<br/>Lymphotoxin-alpha--adverse effects<br/>Medulloblastoma--pathology<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Recombinant Proteins--adverse effects<br/>Subrenal Capsule Assay<br/>Tumor Necrosis Factor-alpha--pharmacology